Abstract 2013: Serum immune markers are associated with pathological complete response and immune-related adverse events in immuno-oncology arms of the I-SPY2 breast cancer trial

Authors: Silver Alkhafaji, Kingsley Chow, Denise Wolf, Rosalyn W. Sayaman, Amrita Basu, Lamorna Brown-Swigart, Rita Nanda, Jo Chien, Minetta Liu, Gillian Hirst, Laura J. Esserman, Laura van 't Veer, Michael J. Campbell

Published: 2025-04-22

DOI: 10.1158/1538-7445.am2025-2013

Source: Full article